Home/Nanospectra Biosciences/David Jorden

DJ

David Jorden

CEO & President

Nanospectra Biosciences

Therapeutic Areas

Nanospectra Biosciences Pipeline

Drug	Indication	Phase
AuroLase Therapy	Localized, low- to intermediate-risk Prostate Cancer	Phase 3

Leadership Team at Nanospectra Biosciences

Dr. Mark R. Hurwitz

Chief Medical Officer

Dr. Naomi J. Halas

Scientific Co-Founder & Advisor

View full Nanospectra Biosciences profile